Zobrazeno 1 - 10
of 759
pro vyhledávání: '"J. Martinez Lopez"'
Autor:
I. Avivi, D. H vesole, J. Dávila Valls, L. Usnarska-Zubkiewicz, V. Milunovic, B. B. Bogumiła Osękowska, A. Kopińska, M. Gentile, B. P. MARTÍNEZ, P. Robak, E. crusoe, R. LUIS GERARDO, M. Gajewska, V. Gergely, M. Delforge, Y. Cohen, G. Alessandro, C. peña, C. Shustik, G. Mikala, K. Žalac, A. H. Denis, B. Peter, K. Weisel, J. martinez lopez, A. Waszczuk-Gajda, M. Krzystanski, A. Jurczyszyn
Publikováno v:
HemaSphere, Vol 6, Pp 782-783 (2022)
Externí odkaz:
https://doaj.org/article/07b6cf6370f14b5ea5ab94db6464b393
Autor:
D. Cubillas, M. Quesada Sanchez, P. Martinez Sanchez, M. Calbacho Robles, J. M. Sanchez Pina, T. Baumann, A. J. Saez, M. Poza, R. Iñiguez, I. Zamanillo, J. Martinez Lopez, A. Jimenez Ubieto
Publikováno v:
HemaSphere, Vol 6, Pp 1213-1214 (2022)
Externí odkaz:
https://doaj.org/article/62c6ccf6ae29434286f67c87f36ec6ca
Autor:
T. J. Gonzalez-Lopez, R. Sanchez, C. Pastoriza, B. Sanchez Gonzalez, P. Olivera, S. Bernat, F. Fernandez-Fuertes, I. Caparrós Miranda, E. Mingot, G. Pérez-Rus, I. Jarque, M. E. Moreno Beltrán, E. López Abadía, E. De Cabo, S. Marcellini, G. Pérez Segura, C. Fernández-Miñano, M. J. Peñarrubia, M. Alvarez, M. A. Fuertes Palacio, J. Martinez Lopez
Publikováno v:
HemaSphere, Vol 6, Pp 1520-1521 (2022)
Externí odkaz:
https://doaj.org/article/35961616e5234562ae4fe8980dc52d8c
Autor:
J. Martinez-Lopez, N. Lopez-Muñoz, A. Chari, S. Dorado, S. Barrio, S. Arora, A. Kumar, A. Chung, T. Martin, J. Wolf
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-6 (2024)
Abstract Minimal residual disease (MRD) assessment is a known surrogate marker for survival in multiple myeloma (MM). Here, we present a single institution’s experience assessing MRD by NGS of Ig genes and the long-term impact of depth of response
Externí odkaz:
https://doaj.org/article/3355d80d7ca1495ba786612c546956f0
Autor:
LJ Costa, NWCJV Donk, L Rosinol, R Popat, Be semer, J Martinez-Lopez, D Trancucci, T Stephenson, K Chastain, N Bahlis
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S515- (2024)
Background: Teclistamab is the first approved B-cell maturation antigen × CD3 bispecific antibody (BsAb) for the treatment of triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM), with weight-based dosing and the longest study foll
Externí odkaz:
https://doaj.org/article/17eb7b3fc61045889fc154c127a9a0cf
Autor:
R Mina, B Dhakal, J San-Miguel, N Lendvai, M Vogel, K Li, D Chen, N Patel, H Einsele, J Martinez-Lopez
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S533-S534 (2024)
Background: The prognosis for patients (pts) with multiple myeloma (MM) who have high-risk (HR) cytogenetics is poor. In the phase 3 CARTITUDE-4 trial, ciltacabtagene autoleucel (cilta-cel) vs standard of care (SOC) significantly improved progression
Externí odkaz:
https://doaj.org/article/5d395560b58f49e3b9b4e47631af7f3b
Autor:
A. Medina-Herrera, I. Vazquez, I. Cuenca, J. M. Rosa-Rosa, B. Ariceta, C. Jimenez, M. Fernandez-Mercado, M. J. Larrayoz, N. C. Gutierrez, M. Fernandez-Guijarro, V. Gonzalez-Calle, P. Rodriguez-Otero, A. Oriol, L. Rosiñol, A. Alegre, F. Escalante, J. De La Rubia, A. I. Teruel, F. De Arriba, M. T. Hernandez, J. Lopez-Jimenez, E. M. Ocio, N. Puig, B. Paiva, J. J. Lahuerta, J. Bladé, J. F. San Miguel, M. V. Mateos, J. Martinez-Lopez, M. J. Calasanz, R. Garcia-Sanz, GEM/PETHEMA (Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas) cooperative study group
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Smoldering multiple myeloma (SMM) precedes multiple myeloma (MM). The risk of progression of SMM patients is not uniform, thus different progression-risk models have been developed, although they are mainly based on clinical parameters. Rece
Externí odkaz:
https://doaj.org/article/1a994d26019e41bc8d283f1ab8ab67d5
Autor:
Umair Munawar, Xiang Zhou, Sabrina Prommersberger, Silvia Nerreter, Cornelia Vogt, Maximilian J. Steinhardt, Marietta Truger, Julia Mersi, Eva Teufel, Seungbin Han, Larissa Haertle, Nicole Banholzer, Patrick Eiring, Sophia Danhof, Miguel Angel Navarro-Aguadero, Adrian Fernandez-Martin, Alejandra Ortiz-Ruiz, Santiago Barrio, Miguel Gallardo, Antonio Valeri, Eva Castellano, Peter Raab, Maximilian Rudert, Claudia Haferlach, Markus Sauer, Michael Hudecek, J. Martinez-Lopez, Johannes Waldschmidt, Hermann Einsele, Leo Rasche, K. Martin Kortüm
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-9 (2023)
Abstract The treatment landscape in multiple myeloma (MM) is shifting from genotoxic drugs to immunotherapies. Monoclonal antibodies, immunoconjugates, T-cell engaging antibodies and CART cells have been incorporated into routine treatment algorithms
Externí odkaz:
https://doaj.org/article/91aba52b6c244a118ef7a4278eff963f
Autor:
N. Lopez-Muñoz, G. Hernández-Ibarburu, R. Alonso, J. M. Sanchez-Pina, R. Ayala, M. Calbacho, C. Cuellar, M. T. Cedena, A. Jiménez-Ubieto, R. Iñiguez, M. Pedrera, J. Cruz, L. Meloni, D. Pérez-Rey, P. Serrano, J. de la Cruz, J. Martinez-Lopez
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-4 (2023)
Abstract Survival in multiple myeloma has improved significantly in recent years, especially in young patients. We reviewed the evolution of the survival of patients with MM in three groups based on age at MM diagnosis over three time periods between
Externí odkaz:
https://doaj.org/article/1dd7a7262c0c4debaf7ec8fe20511024
Autor:
J. Martinez-Lopez, G. Hernandez-Ibarburu, R. Alonso, J. M. Sanchez-Pina, I. Zamanillo, N. Lopez-Muñoz, Rodrigo Iñiguez, C. Cuellar, M. Calbacho, M. L. Paciello, R. Ayala, N. García-Barrio, D. Perez-Rey, L. Meloni, J. Cruz, M. Pedrera-Jiménez, P. Serrano-Balazote, J. de la Cruz
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 12, Pp 1-7 (2021)
Abstract The COVID-19 pandemic has represented a major cause of morbidity/mortality worldwide, overstressing health systems. Multiple myeloma (MM) patients show an increased risk for infections and they are expected to be particularly vulnerable to S
Externí odkaz:
https://doaj.org/article/8c60ab9703dd40aa8633d7de3774cf28